STOCKHOLM – 27 January 2026 – Reference is made to the stock exchange announcement made by Inify Laboratories AB (the "Company") on 12 January 2026 regarding the commencement of the […]
STOCKHOLM – 12 January 2026 – Reference is made to the stock exchange announcement made by Inify Laboratories AB (the "Company") on 19 December 2025 regarding the final results of […]
Stockholm – 19 December 2025 – Inify Laboratories AB (publ) (the "Company") announces that the below primary insider was allocated new shares at the subscription price in the private placement […]
STOCKHOLM – 19 December 2025 – Reference is made to the stock exchange announcement made by Inify Laboratories AB (publ) (the "Company") on 9 December 2025 regarding the fully guaranteed […]
Reference is made to the stock exchange announcement published today, 17 December 2025, regarding the preliminary results of the private placement of new shares (the "Private Placement") in Inify Laboratories […]
STOCKHOLM – 17 December 2025 – Reference is made to the stock exchange announcement made by Inify Laboratories AB (the "Company") on 9 December 2025 regarding the fully guaranteed private […]
Stockholm, Sweden, December 16, 2025; Inify Laboratories AB (publ.) has been notified that the following transactions have been completed by a primary insider in Inify; Fredrik Palm, CEO and primary […]
STOCKHOLM – 9 December 2025 – Reference is made to the stock exchange announcement made by Inify Laboratories AB (the “Company”) on 12 November 2025, regarding a proposed fully guaranteed […]
Today, December 4, 2025, an extraordinary general meeting was held in INIFY Laboratories AB, reg. no. 559345-4431 (the "Company"). At the meeting, 66,655,976 shares were represented, corresponding to 84.5 per […]
STOCKHOLM – December 3, 2025 – The board of directors of Inify Laboratories AB ("Inify" or the "Company") announces its intention to postpone the last date of payment in the […]